What is the projected market valuation of the Computed Tomography Market by 2035?

The Computed Tomography Market is projected to reach a valuation of 11.0 USD Billion by 2035. Read More

What was the market valuation of the Computed Tomography Market in 2024?

In 2024, the Computed Tomography Market was valued at 7.0 USD Billion. Read More

What is the expected CAGR for the Computed Tomography Market during the forecast period 2025 - 2035?

The expected CAGR for the Computed Tomography Market during the forecast period 2025 - 2035 is 4.19%. Read More

Which companies are considered key players in the Computed Tomography Market?

Key players in the Computed Tomography Market include Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems. Read More

What are the primary applications driving the Computed Tomography Market?

The primary applications driving the Computed Tomography Market include Oncology, Cardiology, Neurology, Musculoskeletal, and Pulmonary. Read More

How does the market segment by end use look in terms of valuation?

By end use, the market segments include Hospitals valued at 4.4 USD Billion, Diagnostic Imaging Centers at 2.4 USD Billion, and Outpatient Facilities at 2.6 USD Billion. Read More

What is the market valuation for Pediatric patients in the Computed Tomography Market?

The market valuation for Pediatric patients in the Computed Tomography Market is projected to be between 1.0 and 1.5 USD Billion. Read More

What types of scans are prevalent in the Computed Tomography Market?

Prevalent types of scans in the Computed Tomography Market include Routine Scans, Emergency Scans, and Follow-up Scans. Read More

How does the market segment by patient age group appear in terms of valuation?

The market segments by patient age group show valuations of 6.0 USD Billion for Adults, 3.5 USD Billion for Geriatrics, and 1.5 USD Billion for Pediatrics. Read More

computed tomography market

Q: What technologies are contributing to the growth of the Computed Tomography Market?

Technologies contributing to the growth include Computed Tomography Angiography, Dual Energy Computed Tomography, and Portable Computed Tomography. Read More

ID: MRFR/HC/64479-HCR

200 Pages

Satyendra Maurya

Last Updated: March 28, 2026

Computed Tomography Market Research Report: Size, Share, Trend Analysis By End Use (Hospitals, Diagnostic Imaging Centers, Research Institutions, Outpatient Facilities), By Technology (Computed Tomography Angiography, Dual Energy Computed Tomography, Cone Beam Computed Tomography, Portable Computed Tomography), By Application (Oncology, Cardiology, Neurology, Musculoskeletal, Pulmonary), By Type of Scan (Routine Scan, Emergency Scan, Follow-up Scan), By Patient Age Group (Pediatric, Adult, Geriatric) – Growth Outlook & Industry Forecast To 2035

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1.1 EXECUTIVE SUMMARY
1.1.1 Market Overview
1.1.2 Key Findings
1.1.3 Market Segmentation
1.1.4 Competitive Landscape
1.1.5 Challenges and Opportunities
1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
2.1 MARKET INTRODUCTION
2.1.1 Definition
2.1.2 Scope of the study
2.1.2.1 Research Objective
2.1.2.2 Assumption
2.1.2.3 Limitations
2.2 RESEARCH METHODOLOGY
2.2.1 Overview
2.2.2 Data Mining
2.2.3 Secondary Research
2.2.4 Primary Research
2.2.4.1 Primary Interviews and Information Gathering Process
2.2.4.2 Breakdown of Primary Respondents
2.2.5 Forecasting Model
2.2.6 Market Size Estimation
2.2.6.1 Bottom-Up Approach
2.2.6.2 Top-Down Approach
2.2.7 Data Triangulation
2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
3.1 MARKET DYNAMICS
3.1.1 Overview
3.1.2 Drivers
3.1.3 Restraints
3.1.4 Opportunities
3.2 MARKET FACTOR ANALYSIS
3.2.1 Value chain Analysis
3.2.2 Porter's Five Forces Analysis
3.2.2.1 Bargaining Power of Suppliers
3.2.2.2 Bargaining Power of Buyers
3.2.2.3 Threat of New Entrants
3.2.2.4 Threat of Substitutes
3.2.2.5 Intensity of Rivalry
3.2.3 COVID-19 Impact Analysis
3.2.3.1 Market Impact Analysis
3.2.3.2 Regional Impact
3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
4.1 Healthcare, BY Application (USD Billion)
4.1.1 Oncology
4.1.2 Cardiology
4.1.3 Neurology
4.1.4 Musculoskeletal
4.1.5 Pulmonary
4.2 Healthcare, BY End Use (USD Billion)
4.2.1 Hospitals
4.2.2 Diagnostic Imaging Centers
4.2.3 Research Institutions
4.2.4 Outpatient Facilities
4.3 Healthcare, BY Technology (USD Billion)
4.3.1 Computed Tomography Angiography
4.3.2 Dual Energy Computed Tomography
4.3.3 Cone Beam Computed Tomography
4.3.4 Portable Computed Tomography
4.4 Healthcare, BY Patient Age Group (USD Billion)
4.4.1 Pediatric
4.4.2 Adult
4.4.3 Geriatric
4.5 Healthcare, BY Type of Scan (USD Billion)
4.5.1 Routine Scan
4.5.2 Emergency Scan
4.5.3 Follow-up Scan
4.6 Healthcare, BY Region (USD Billion)
4.6.1 North America
4.6.1.1 US
4.6.1.2 Canada
4.6.2 Europe
4.6.2.1 Germany
4.6.2.2 UK
4.6.2.3 France
4.6.2.4 Russia
4.6.2.5 Italy
4.6.2.6 Spain
4.6.2.7 Rest of Europe
4.6.3 APAC
4.6.3.1 China
4.6.3.2 India
4.6.3.3 Japan
4.6.3.4 South Korea
4.6.3.5 Malaysia
4.6.3.6 Thailand
4.6.3.7 Indonesia
4.6.3.8 Rest of APAC
4.6.4 South America
4.6.4.1 Brazil
4.6.4.2 Mexico
4.6.4.3 Argentina
4.6.4.4 Rest of South America
4.6.5 MEA
4.6.5.1 GCC Countries
4.6.5.2 South Africa
4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
5.1 Competitive Landscape
5.1.1 Overview
5.1.2 Competitive Analysis
5.1.3 Market share Analysis
5.1.4 Major Growth Strategy in the Healthcare
5.1.5 Competitive Benchmarking
5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
5.1.7 Key developments and growth strategies
5.1.7.1 New Product Launch/Service Deployment
5.1.7.2 Merger & Acquisitions
5.1.7.3 Joint Ventures
5.1.8 Major Players Financial Matrix
5.1.8.1 Sales and Operating Income
5.1.8.2 Major Players R&D Expenditure. 2023
5.2 Company Profiles
5.2.1 Siemens Healthineers (DE)
5.2.1.1 Financial Overview
5.2.1.2 Products Offered
5.2.1.3 Key Developments
5.2.1.4 SWOT Analysis
5.2.1.5 Key Strategies
5.2.2 GE Healthcare (US)
5.2.2.1 Financial Overview
5.2.2.2 Products Offered
5.2.2.3 Key Developments
5.2.2.4 SWOT Analysis
5.2.2.5 Key Strategies
5.2.3 Philips Healthcare (NL)
5.2.3.1 Financial Overview
5.2.3.2 Products Offered
5.2.3.3 Key Developments
5.2.3.4 SWOT Analysis
5.2.3.5 Key Strategies
5.2.4 Canon Medical Systems (JP)
5.2.4.1 Financial Overview
5.2.4.2 Products Offered
5.2.4.3 Key Developments
5.2.4.4 SWOT Analysis
5.2.4.5 Key Strategies
5.2.5 Fujifilm Holdings Corporation (JP)
5.2.5.1 Financial Overview
5.2.5.2 Products Offered
5.2.5.3 Key Developments
5.2.5.4 SWOT Analysis
5.2.5.5 Key Strategies
5.2.6 Hitachi Medical Corporation (JP)
5.2.6.1 Financial Overview
5.2.6.2 Products Offered
5.2.6.3 Key Developments
5.2.6.4 SWOT Analysis
5.2.6.5 Key Strategies
5.2.7 Agfa-Gevaert Group (BE)
5.2.7.1 Financial Overview
5.2.7.2 Products Offered
5.2.7.3 Key Developments
5.2.7.4 SWOT Analysis
5.2.7.5 Key Strategies
5.2.8 Carestream Health (US)
5.2.8.1 Financial Overview
5.2.8.2 Products Offered
5.2.8.3 Key Developments
5.2.8.4 SWOT Analysis
5.2.8.5 Key Strategies
5.2.9 Samsung Medison (KR)
5.2.9.1 Financial Overview
5.2.9.2 Products Offered
5.2.9.3 Key Developments
5.2.9.4 SWOT Analysis
5.2.9.5 Key Strategies
5.3 Appendix
5.3.1 References
5.3.2 Related Reports
6 LIST OF FIGURES
6.1 MARKET SYNOPSIS
6.2 NORTH AMERICA MARKET ANALYSIS
6.3 US MARKET ANALYSIS BY APPLICATION
6.4 US MARKET ANALYSIS BY END USE
6.5 US MARKET ANALYSIS BY TECHNOLOGY
6.6 US MARKET ANALYSIS BY PATIENT AGE GROUP
6.7 US MARKET ANALYSIS BY TYPE OF SCAN
6.8 CANADA MARKET ANALYSIS BY APPLICATION
6.9 CANADA MARKET ANALYSIS BY END USE
6.10 CANADA MARKET ANALYSIS BY TECHNOLOGY
6.11 CANADA MARKET ANALYSIS BY PATIENT AGE GROUP
6.12 CANADA MARKET ANALYSIS BY TYPE OF SCAN
6.13 EUROPE MARKET ANALYSIS
6.14 GERMANY MARKET ANALYSIS BY APPLICATION
6.15 GERMANY MARKET ANALYSIS BY END USE
6.16 GERMANY MARKET ANALYSIS BY TECHNOLOGY
6.17 GERMANY MARKET ANALYSIS BY PATIENT AGE GROUP
6.18 GERMANY MARKET ANALYSIS BY TYPE OF SCAN
6.19 UK MARKET ANALYSIS BY APPLICATION
6.20 UK MARKET ANALYSIS BY END USE
6.21 UK MARKET ANALYSIS BY TECHNOLOGY
6.22 UK MARKET ANALYSIS BY PATIENT AGE GROUP
6.23 UK MARKET ANALYSIS BY TYPE OF SCAN
6.24 FRANCE MARKET ANALYSIS BY APPLICATION
6.25 FRANCE MARKET ANALYSIS BY END USE
6.26 FRANCE MARKET ANALYSIS BY TECHNOLOGY
6.27 FRANCE MARKET ANALYSIS BY PATIENT AGE GROUP
6.28 FRANCE MARKET ANALYSIS BY TYPE OF SCAN
6.29 RUSSIA MARKET ANALYSIS BY APPLICATION
6.30 RUSSIA MARKET ANALYSIS BY END USE
6.31 RUSSIA MARKET ANALYSIS BY TECHNOLOGY
6.32 RUSSIA MARKET ANALYSIS BY PATIENT AGE GROUP
6.33 RUSSIA MARKET ANALYSIS BY TYPE OF SCAN
6.34 ITALY MARKET ANALYSIS BY APPLICATION
6.35 ITALY MARKET ANALYSIS BY END USE
6.36 ITALY MARKET ANALYSIS BY TECHNOLOGY
6.37 ITALY MARKET ANALYSIS BY PATIENT AGE GROUP
6.38 ITALY MARKET ANALYSIS BY TYPE OF SCAN
6.39 SPAIN MARKET ANALYSIS BY APPLICATION
6.40 SPAIN MARKET ANALYSIS BY END USE
6.41 SPAIN MARKET ANALYSIS BY TECHNOLOGY
6.42 SPAIN MARKET ANALYSIS BY PATIENT AGE GROUP
6.43 SPAIN MARKET ANALYSIS BY TYPE OF SCAN
6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
6.45 REST OF EUROPE MARKET ANALYSIS BY END USE
6.46 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY
6.47 REST OF EUROPE MARKET ANALYSIS BY PATIENT AGE GROUP
6.48 REST OF EUROPE MARKET ANALYSIS BY TYPE OF SCAN
6.49 APAC MARKET ANALYSIS
6.50 CHINA MARKET ANALYSIS BY APPLICATION
6.51 CHINA MARKET ANALYSIS BY END USE
6.52 CHINA MARKET ANALYSIS BY TECHNOLOGY
6.53 CHINA MARKET ANALYSIS BY PATIENT AGE GROUP
6.54 CHINA MARKET ANALYSIS BY TYPE OF SCAN
6.55 INDIA MARKET ANALYSIS BY APPLICATION
6.56 INDIA MARKET ANALYSIS BY END USE
6.57 INDIA MARKET ANALYSIS BY TECHNOLOGY
6.58 INDIA MARKET ANALYSIS BY PATIENT AGE GROUP
6.59 INDIA MARKET ANALYSIS BY TYPE OF SCAN
6.60 JAPAN MARKET ANALYSIS BY APPLICATION
6.61 JAPAN MARKET ANALYSIS BY END USE
6.62 JAPAN MARKET ANALYSIS BY TECHNOLOGY
6.63 JAPAN MARKET ANALYSIS BY PATIENT AGE GROUP
6.64 JAPAN MARKET ANALYSIS BY TYPE OF SCAN
6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
6.66 SOUTH KOREA MARKET ANALYSIS BY END USE
6.67 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
6.68 SOUTH KOREA MARKET ANALYSIS BY PATIENT AGE GROUP
6.69 SOUTH KOREA MARKET ANALYSIS BY TYPE OF SCAN
6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION
6.71 MALAYSIA MARKET ANALYSIS BY END USE
6.72 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY
6.73 MALAYSIA MARKET ANALYSIS BY PATIENT AGE GROUP
6.74 MALAYSIA MARKET ANALYSIS BY TYPE OF SCAN
6.75 THAILAND MARKET ANALYSIS BY APPLICATION
6.76 THAILAND MARKET ANALYSIS BY END USE
6.77 THAILAND MARKET ANALYSIS BY TECHNOLOGY
6.78 THAILAND MARKET ANALYSIS BY PATIENT AGE GROUP
6.79 THAILAND MARKET ANALYSIS BY TYPE OF SCAN
6.80 INDONESIA MARKET ANALYSIS BY APPLICATION
6.81 INDONESIA MARKET ANALYSIS BY END USE
6.82 INDONESIA MARKET ANALYSIS BY TECHNOLOGY
6.83 INDONESIA MARKET ANALYSIS BY PATIENT AGE GROUP
6.84 INDONESIA MARKET ANALYSIS BY TYPE OF SCAN
6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION
6.86 REST OF APAC MARKET ANALYSIS BY END USE
6.87 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY
6.88 REST OF APAC MARKET ANALYSIS BY PATIENT AGE GROUP
6.89 REST OF APAC MARKET ANALYSIS BY TYPE OF SCAN
6.90 SOUTH AMERICA MARKET ANALYSIS
6.91 BRAZIL MARKET ANALYSIS BY APPLICATION
6.92 BRAZIL MARKET ANALYSIS BY END USE
6.93 BRAZIL MARKET ANALYSIS BY TECHNOLOGY
6.94 BRAZIL MARKET ANALYSIS BY PATIENT AGE GROUP
6.95 BRAZIL MARKET ANALYSIS BY TYPE OF SCAN
6.96 MEXICO MARKET ANALYSIS BY APPLICATION
6.97 MEXICO MARKET ANALYSIS BY END USE
6.98 MEXICO MARKET ANALYSIS BY TECHNOLOGY
6.99 MEXICO MARKET ANALYSIS BY PATIENT AGE GROUP
6.100 MEXICO MARKET ANALYSIS BY TYPE OF SCAN
6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION
6.102 ARGENTINA MARKET ANALYSIS BY END USE
6.103 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY
6.104 ARGENTINA MARKET ANALYSIS BY PATIENT AGE GROUP
6.105 ARGENTINA MARKET ANALYSIS BY TYPE OF SCAN
6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY PATIENT AGE GROUP
6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE OF SCAN
6.111 MEA MARKET ANALYSIS
6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
6.113 GCC COUNTRIES MARKET ANALYSIS BY END USE
6.114 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY
6.115 GCC COUNTRIES MARKET ANALYSIS BY PATIENT AGE GROUP
6.116 GCC COUNTRIES MARKET ANALYSIS BY TYPE OF SCAN
6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
6.118 SOUTH AFRICA MARKET ANALYSIS BY END USE
6.119 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY
6.120 SOUTH AFRICA MARKET ANALYSIS BY PATIENT AGE GROUP
6.121 SOUTH AFRICA MARKET ANALYSIS BY TYPE OF SCAN
6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION
6.123 REST OF MEA MARKET ANALYSIS BY END USE
6.124 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY
6.125 REST OF MEA MARKET ANALYSIS BY PATIENT AGE GROUP
6.126 REST OF MEA MARKET ANALYSIS BY TYPE OF SCAN
6.127 KEY BUYING CRITERIA OF HEALTHCARE
6.128 RESEARCH PROCESS OF MRFR
6.129 DRO ANALYSIS OF HEALTHCARE
6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
6.133 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
6.134 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
6.135 HEALTHCARE, BY END USE, 2024 (% SHARE)
6.136 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
6.137 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
6.138 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
6.139 HEALTHCARE, BY PATIENT AGE GROUP, 2024 (% SHARE)
6.140 HEALTHCARE, BY PATIENT AGE GROUP, 2024 TO 2035 (USD Billion)
6.141 HEALTHCARE, BY TYPE OF SCAN, 2024 (% SHARE)
6.142 HEALTHCARE, BY TYPE OF SCAN, 2024 TO 2035 (USD Billion)
6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
7.1 LIST OF ASSUMPTIONS
7.1.1
7.2 North America MARKET SIZE ESTIMATES; FORECAST
7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
7.2.2 BY END USE, 2025-2035 (USD Billion)
7.2.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.2.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.2.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.3 US MARKET SIZE ESTIMATES; FORECAST
7.3.1 BY APPLICATION, 2025-2035 (USD Billion)
7.3.2 BY END USE, 2025-2035 (USD Billion)
7.3.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.3.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.3.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.4 Canada MARKET SIZE ESTIMATES; FORECAST
7.4.1 BY APPLICATION, 2025-2035 (USD Billion)
7.4.2 BY END USE, 2025-2035 (USD Billion)
7.4.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.4.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.4.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.5 Europe MARKET SIZE ESTIMATES; FORECAST
7.5.1 BY APPLICATION, 2025-2035 (USD Billion)
7.5.2 BY END USE, 2025-2035 (USD Billion)
7.5.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.5.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.5.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.6 Germany MARKET SIZE ESTIMATES; FORECAST
7.6.1 BY APPLICATION, 2025-2035 (USD Billion)
7.6.2 BY END USE, 2025-2035 (USD Billion)
7.6.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.6.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.6.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.7 UK MARKET SIZE ESTIMATES; FORECAST
7.7.1 BY APPLICATION, 2025-2035 (USD Billion)
7.7.2 BY END USE, 2025-2035 (USD Billion)
7.7.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.7.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.7.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.8 France MARKET SIZE ESTIMATES; FORECAST
7.8.1 BY APPLICATION, 2025-2035 (USD Billion)
7.8.2 BY END USE, 2025-2035 (USD Billion)
7.8.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.8.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.8.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.9 Russia MARKET SIZE ESTIMATES; FORECAST
7.9.1 BY APPLICATION, 2025-2035 (USD Billion)
7.9.2 BY END USE, 2025-2035 (USD Billion)
7.9.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.9.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.9.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.10 Italy MARKET SIZE ESTIMATES; FORECAST
7.10.1 BY APPLICATION, 2025-2035 (USD Billion)
7.10.2 BY END USE, 2025-2035 (USD Billion)
7.10.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.10.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.10.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.11 Spain MARKET SIZE ESTIMATES; FORECAST
7.11.1 BY APPLICATION, 2025-2035 (USD Billion)
7.11.2 BY END USE, 2025-2035 (USD Billion)
7.11.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.11.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.11.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
7.12.1 BY APPLICATION, 2025-2035 (USD Billion)
7.12.2 BY END USE, 2025-2035 (USD Billion)
7.12.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.12.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.12.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.13 APAC MARKET SIZE ESTIMATES; FORECAST
7.13.1 BY APPLICATION, 2025-2035 (USD Billion)
7.13.2 BY END USE, 2025-2035 (USD Billion)
7.13.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.13.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.13.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.14 China MARKET SIZE ESTIMATES; FORECAST
7.14.1 BY APPLICATION, 2025-2035 (USD Billion)
7.14.2 BY END USE, 2025-2035 (USD Billion)
7.14.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.14.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.14.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.15 India MARKET SIZE ESTIMATES; FORECAST
7.15.1 BY APPLICATION, 2025-2035 (USD Billion)
7.15.2 BY END USE, 2025-2035 (USD Billion)
7.15.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.15.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.15.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.16 Japan MARKET SIZE ESTIMATES; FORECAST
7.16.1 BY APPLICATION, 2025-2035 (USD Billion)
7.16.2 BY END USE, 2025-2035 (USD Billion)
7.16.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.16.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.16.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
7.17.1 BY APPLICATION, 2025-2035 (USD Billion)
7.17.2 BY END USE, 2025-2035 (USD Billion)
7.17.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.17.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.17.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
7.18.1 BY APPLICATION, 2025-2035 (USD Billion)
7.18.2 BY END USE, 2025-2035 (USD Billion)
7.18.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.18.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.18.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
7.19.1 BY APPLICATION, 2025-2035 (USD Billion)
7.19.2 BY END USE, 2025-2035 (USD Billion)
7.19.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.19.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.19.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
7.20.1 BY APPLICATION, 2025-2035 (USD Billion)
7.20.2 BY END USE, 2025-2035 (USD Billion)
7.20.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.20.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.20.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
7.21.1 BY APPLICATION, 2025-2035 (USD Billion)
7.21.2 BY END USE, 2025-2035 (USD Billion)
7.21.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.21.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.21.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.22 South America MARKET SIZE ESTIMATES; FORECAST
7.22.1 BY APPLICATION, 2025-2035 (USD Billion)
7.22.2 BY END USE, 2025-2035 (USD Billion)
7.22.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.22.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.22.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
7.23.1 BY APPLICATION, 2025-2035 (USD Billion)
7.23.2 BY END USE, 2025-2035 (USD Billion)
7.23.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.23.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.23.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
7.24.1 BY APPLICATION, 2025-2035 (USD Billion)
7.24.2 BY END USE, 2025-2035 (USD Billion)
7.24.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.24.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.24.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
7.25.1 BY APPLICATION, 2025-2035 (USD Billion)
7.25.2 BY END USE, 2025-2035 (USD Billion)
7.25.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.25.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.25.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
7.26.1 BY APPLICATION, 2025-2035 (USD Billion)
7.26.2 BY END USE, 2025-2035 (USD Billion)
7.26.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.26.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.26.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.27 MEA MARKET SIZE ESTIMATES; FORECAST
7.27.1 BY APPLICATION, 2025-2035 (USD Billion)
7.27.2 BY END USE, 2025-2035 (USD Billion)
7.27.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.27.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.27.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
7.28.1 BY APPLICATION, 2025-2035 (USD Billion)
7.28.2 BY END USE, 2025-2035 (USD Billion)
7.28.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.28.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.28.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
7.29.1 BY APPLICATION, 2025-2035 (USD Billion)
7.29.2 BY END USE, 2025-2035 (USD Billion)
7.29.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.29.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.29.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
7.30.1 BY APPLICATION, 2025-2035 (USD Billion)
7.30.2 BY END USE, 2025-2035 (USD Billion)
7.30.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.30.4 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
7.30.5 BY TYPE OF SCAN, 2025-2035 (USD Billion)
7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2025-2035)

Oncology
Cardiology
Neurology
Musculoskeletal
Pulmonary

Healthcare By End Use (USD Billion, 2025-2035)

Hospitals
Diagnostic Imaging Centers
Research Institutions
Outpatient Facilities

Healthcare By Technology (USD Billion, 2025-2035)

Computed Tomography Angiography
Dual Energy Computed Tomography
Cone Beam Computed Tomography
Portable Computed Tomography

Healthcare By Patient Age Group (USD Billion, 2025-2035)

Pediatric
Adult
Geriatric

Healthcare By Type of Scan (USD Billion, 2025-2035)

Routine Scan
Emergency Scan
Follow-up Scan

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓